Clover Health Investments Price to Book Ratio 2020-2025 | CLOV
Historical price to book ratio values for Clover Health Investments (CLOV) over the last 10 years. The current price to book ratio for Clover Health Investments as of May 20, 2025 is 5.43.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Clover Health Investments Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-20 | 3.69 | 5.56 | |
| 2025-03-31 | 3.59 | $0.66 | 5.41 |
| 2024-12-31 | 3.15 | $0.68 | 4.65 |
| 2024-09-30 | 2.82 | $0.68 | 4.12 |
| 2024-06-30 | 1.23 | $0.65 | 1.88 |
| 2024-03-31 | 0.79 | $0.59 | 1.35 |
| 2023-12-31 | 0.95 | $0.59 | 1.63 |
| 2023-09-30 | 1.08 | $0.66 | 1.63 |
| 2023-06-30 | 0.90 | $0.68 | 1.31 |
| 2023-03-31 | 0.85 | $0.67 | 1.26 |
| 2022-12-31 | 0.93 | $0.75 | 1.25 |
| 2022-09-30 | 1.70 | $0.82 | 2.07 |
| 2022-06-30 | 2.14 | $0.89 | 2.39 |
| 2022-03-31 | 3.55 | $1.03 | 3.43 |
| 2021-12-31 | 3.72 | $1.15 | 3.25 |
| 2021-09-30 | 7.39 | $0.98 | 7.54 |
| 2021-06-30 | 13.15 | $0.77 | 17.05 |
| 2021-03-31 | 7.46 | $1.44 | 5.17 |
| 2020-12-31 | 16.55 | $-6.87 | -2.41 |
| 2020-09-30 | 12.30 | $0.21 | 59.59 |
| 2020-06-30 | 11.04 | $0.21 | 52.95 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.832B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.988B | 53.85 |
| Hims & Hers Health (HIMS) | United States | $13.954B | 144.98 |
| Tempus AI (TEM) | United States | $10.977B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.526B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.418B | 69.02 |
| Privia Health (PRVA) | United States | $3.048B | 208.33 |
| Enovis (ENOV) | United States | $2.027B | 11.30 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.305B | 23.02 |
| Azenta (AZTA) | United States | $1.242B | 57.70 |
| 10x Genomics (TXG) | United States | $1.100B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.574B | 0.00 |
| Talkspace (TALK) | United States | $0.504B | 150.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.452B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.00 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.231B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.34 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |